Home
Medicines
Active Ingredients
Companies
DHPC
Advanced Search
Adverse Event Reporting
Login
Medicines.ie | Reliable & Accurate Online Medicines Information | Home page
Home Medicines Active Ingredients Companies DHPC Advanced Search Adverse Event Reporting
Login
  • Home
  • Active Ingredients
  • Daratumumab

Daratumumab

Medicine Status PIL SPC XPIL Legal Category Active Ingredient(s) Company
DARZALEX 1,800 mg solution for injection
Updated
PIL 03/03/22 SPC 25/03/22 NoA
Daratumumab
Janssen Sciences Ireland
DARZALEX 20 mg/mL concentrate for solution for infusion.
Updated
PIL 12/01/22 SPC 25/03/22 NoA
Daratumumab
Janssen Sciences Ireland

Brought to you by

Irish Pharmaceutical Healthcare Association | Home page

About

  • Help
  • About
  • Contact Us

Legal

  • Privacy Statement
  • Terms & Conditions
  • Accessibility

Search

  • Medicines
  • Active Ingredients
  • Companies

Award

Pharma Industry Awards 2020, Innovation of the Year, 2nd Place
Designed by eConcept Web Solutions
Direct Healthcare Professional Communications
Documents associated with this medicine were updated in the last 30 days.
Date of Update on Medicines.ie
Product subject to medical prescription which may not be renewed (A)